Hexo Completes $925M Redecan Acquisition On Its 'Path Towards Positive EPS'

HEXO Corp HEXO HEXO announced Monday the completion of the previously announced $925 million acquisition of Redecan, Canada’s largest privately-owned licensed producer.

At closing, HEXO paid the selling shareholders of Redecan $400 million in cash (subject to certain customary closing adjustments) and delivered 69.7 million newly issued common shares of HEXO.

“This is an exciting day for HEXO and Redecan employees, investors, consumers and stakeholders,” HEXO CEO and co-founder Sebastien St-Louis said. “The completion of this transaction is aligned with our corporate growth strategy and will further strengthen our position as a leader in the Canadian cannabis industry, bolstering the combined company as we look towards becoming a top three global cannabis products company and continue on the path towards positive EPS.”

In connection with the closing of the transaction, HEXO entered into an investor rights agreement with certain Redecan sellers to provide for certain customary governance rights, including limited demand and piggyback registration rights. Furthermore, pursuant to the share purchase agreement entered into in connection with the transaction, the resale of the consideration shares by Redecan sellers will be restricted by a 24-month hold period.

Pursuant to the transaction and terms of the Investor Rights Agreement, Peter James Montour joins the HEXO board of directors, which also includes Emilio Imbriglio, Vincent Chiara, Jason Ewart, Adam Miron, Michael Munzar, Sébastien St-Louis and Rose Marie Gage. Will Montour will act as a non-voting observer on the board of directors until his election to the board in accordance with the Investor Rights Agreement.

More recent news from Hexo:

EXCLUSIVE: Why Canadian Cannabis Companies With US Operations Can Still List On NYSE & NASDAQ?

 HEXO's Stock On Rise Again As Shareholders Approve Redecan Acquisition

HEXO's Stock Continues To Drop After Switching To NASDAQ

Price Action

Hexo’s shares were trading 1.23% higher at $2.46 per share during Tuesday's pre-market session.

Photo: Courtesy of Daniel Norin on Unsplash

Posted In: Adam MironEmilio ImbriglioHexo Redecan acquistionJason EwartMichael MunzarPeter James MontourRose Marie GageSebastien St-LouisVincent ChiaraWill MontourCannabisNewsPenny StocksSmall CapMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.